Unraveling the Pathophysiological Role of the BRAFV600E Mutation in Langerhans Cell Histiocytosis (LCH) and its Therapeutical Implications with Murine Models of High-Risk LCH
Research Infrastructure for Clinical and Translational Research in Langerhans Cell Histiocytosis (LCH)